Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
Afamitresgene autoleucel
Katy, TX
See all hospitals reporting HCPCS Q2057 →Price type
Houston Methodist Continuing Care Hospital’s median price of $4558.2k is 463% above the median hospital's median price ($810.1k), higher than 100% of the 860 hospitals reporting HCPCS Q2057. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Negotiated rates from the hospital’s own file: 1 payer, 1 plan rate. A facility fee, a professional fee, a per diem and a case rate are different bills, so each is listed on its own. Open a payer to see it across hospitals.
Filter by billing methodology
Filter by billing class
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | UnitedHealthcare all commercial plans fee schedule · outpatient | $4558.2k | $4558.2k | — | — | — | $4558.2k – $4558.2k |
Last updated: Apr 1, 2026
See Afamitresgene cell therapy dose with collection and preparation pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.